| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
138,140,000 |
| Market
Cap: |
142.28(M) |
| Last
Volume: |
3,241,097 |
Avg
Vol: |
3,311,042 |
| 52
Week Range: |
$0.937 - $1.31 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 807 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Spectrum Pharmaceuticals is a biopharmaceutical company. Co. is engaged in acquiring, developing, and commercializing targeted oncology therapies. Co. has two drugs in late-stage development: Eflapegrastim, which is a long-acting granulocyte colony-stimulating factor for the treatment of chemotherapy-induced neutropenia; as well as Poziotinib, which is an irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer tumors with various mutations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$22,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
32,387 |
490,738 |
| Total Sell Value |
$0 |
$0 |
$35,496 |
$343,474 |
| Total People Sold |
0 |
0 |
1 |
7 |
| Total Sell Transactions |
0 |
0 |
1 |
19 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lenaz Luigi Md |
Director |
– • – |
2013-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
39,077 |
|
- |
|
| Krassner Stuart Mitchell |
Director |
– • – |
2013-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,000 |
|
- |
|
| Cohen Raymond W |
Director |
– • – |
2013-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2013-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
17,550 |
|
- |
|
| Vyas Dolatrai |
Director |
– • – |
2013-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2013-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
1,878,303 |
|
- |
|
| Gagnon Gilles |
Director |
– • – |
2013-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
45,000 |
|
- |
|
| Turgeon Joseph W. |
Chief Commercial Officer |
• – – |
2013-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
75,000 |
|
- |
|
| Keller Joseph Kenneth |
EVP & Chief Operating Officer |
• – – |
2013-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
168,000 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2013-11-29 |
4 |
D |
$9.59 |
$603,451 |
D/D |
(62,925) |
1,798,303 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2013-09-04 |
4 |
OE |
$1.99 |
$1,378,582 |
D/D |
403,948 |
1,861,228 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2013-06-11 |
5 |
GD |
$0.00 |
$0 |
D/D |
3,482 |
1,832,849 |
|
- |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2013-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
|
- |
|
| Allen Lee F Md Phd |
Chief Medical OfficerOfficer |
• – – |
2013-04-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
45,000 |
|
- |
|
| Turgeon Joseph W. |
Chief Commercial OfficerOffice |
• – – |
2013-04-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,000 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2013-03-05 |
4 |
AS |
$11.50 |
$57,499 |
D/D |
(5,000) |
7,550 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2013-03-05 |
4 |
OE |
$3.92 |
$19,600 |
D/D |
5,000 |
12,550 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2013-02-05 |
4 |
AS |
$12.25 |
$61,245 |
D/D |
(5,000) |
2,250 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2013-02-05 |
4 |
OE |
$3.92 |
$20,722 |
D/D |
5,000 |
3,950 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2013-01-03 |
4 |
D |
$11.66 |
$272,191 |
D/D |
(23,344) |
1,460,762 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2013-01-02 |
4 |
AS |
$11.42 |
$57,109 |
D/D |
(5,000) |
2,250 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2013-01-02 |
4 |
OE |
$4.26 |
$21,300 |
D/D |
5,000 |
7,250 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2012-12-31 |
4 |
S |
$11.24 |
$2,313,267 |
D/D |
(205,836) |
1,484,106 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2012-12-28 |
4 |
S |
$11.35 |
$1,957,954 |
D/D |
(172,507) |
1,689,942 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-12-20 |
5 |
GD |
$0.00 |
$0 |
I/I |
2,823 |
57,177 |
|
- |
|
658 Records found
|
|
Page 20 of 27 |
|
|
